Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster

Visceral leishmaniasis (VL) is a fatal disease caused by the protozoa Leishmania infantum for which dogs are the main reservoirs. A vaccine against canine visceral leishmaniasis (CVL) could be an important tool in the control of human and CVL by reducing the infection pressure of L. infantum. Despit...

Full description

Bibliographic Details
Main Authors: Maia Gonçalves, Ana Alice, Ottino, Jennifer, Costa Leite, Jaqueline, Aparecida Resende, Lucilene, Melo Júnior, Otoni Alves, Silveira, Patrícia, Santos Cardoso, Mariana, Toshio Fujiwara, Ricardo, Lacerda Bueno, Lilian, Lima Santos, Renato, Furtado de Carvalho, Tatiane, Martins Garcia, Giani, de Oliveira Paes, Paulo Ricardo, Sobreira Galdino, Alexsandro, Chávez Fumagalli, Miguel Angel, Martins Melo, Marília, Silveira Lemos, Denise, Martins Filho, Olindo Assis, Ornelas Dutra, Walderez, Furtado Mosqueira, Vanessa Carla, Cordeiro Giunchetti, Rodolfo
Format: Artículo
Language:Inglés
Published: MDPI 2023
Subjects:
Online Access:https://hdl.handle.net/20.500.12955/2090
https://doi.org/10.3390/vaccines11010111
_version_ 1855490540415483904
author Maia Gonçalves, Ana Alice
Ottino, Jennifer
Costa Leite, Jaqueline
Aparecida Resende, Lucilene
Melo Júnior, Otoni Alves
Silveira, Patrícia
Santos Cardoso, Mariana
Toshio Fujiwara, Ricardo
Lacerda Bueno, Lilian
Lima Santos, Renato
Furtado de Carvalho, Tatiane
Martins Garcia, Giani
de Oliveira Paes, Paulo Ricardo
Sobreira Galdino, Alexsandro
Chávez Fumagalli, Miguel Angel
Martins Melo, Marília
Silveira Lemos, Denise
Martins Filho, Olindo Assis
Ornelas Dutra, Walderez
Furtado Mosqueira, Vanessa Carla
Cordeiro Giunchetti, Rodolfo
author_browse Aparecida Resende, Lucilene
Chávez Fumagalli, Miguel Angel
Cordeiro Giunchetti, Rodolfo
Costa Leite, Jaqueline
Furtado Mosqueira, Vanessa Carla
Furtado de Carvalho, Tatiane
Lacerda Bueno, Lilian
Lima Santos, Renato
Maia Gonçalves, Ana Alice
Martins Filho, Olindo Assis
Martins Garcia, Giani
Martins Melo, Marília
Melo Júnior, Otoni Alves
Ornelas Dutra, Walderez
Ottino, Jennifer
Santos Cardoso, Mariana
Silveira Lemos, Denise
Silveira, Patrícia
Sobreira Galdino, Alexsandro
Toshio Fujiwara, Ricardo
de Oliveira Paes, Paulo Ricardo
author_facet Maia Gonçalves, Ana Alice
Ottino, Jennifer
Costa Leite, Jaqueline
Aparecida Resende, Lucilene
Melo Júnior, Otoni Alves
Silveira, Patrícia
Santos Cardoso, Mariana
Toshio Fujiwara, Ricardo
Lacerda Bueno, Lilian
Lima Santos, Renato
Furtado de Carvalho, Tatiane
Martins Garcia, Giani
de Oliveira Paes, Paulo Ricardo
Sobreira Galdino, Alexsandro
Chávez Fumagalli, Miguel Angel
Martins Melo, Marília
Silveira Lemos, Denise
Martins Filho, Olindo Assis
Ornelas Dutra, Walderez
Furtado Mosqueira, Vanessa Carla
Cordeiro Giunchetti, Rodolfo
author_sort Maia Gonçalves, Ana Alice
collection Repositorio INIA
description Visceral leishmaniasis (VL) is a fatal disease caused by the protozoa Leishmania infantum for which dogs are the main reservoirs. A vaccine against canine visceral leishmaniasis (CVL) could be an important tool in the control of human and CVL by reducing the infection pressure of L. infantum. Despite the CVL vaccine available on the market, the Brazilian Ministry of Health did not implement the use of it in their control programs. In this sense, there is an urgent need to develop more efficient vaccines. In this study, the association between two polymeric nanoformulations, (poly (D, L-lactic) acid (PLA) polymer) loading Leishmania amazonensis antigens, was evaluated as a potential immunobiological agent against VL using golden hamsters as an experimental model. The results indicated that no significant adverse reactions were observed in animals vaccinated with LAPSmP. LAPSmP presented similar levels of total anti-Leishmania IgG as compared to LAPSmG. The LAPSmP and LAPSmG groups showed an intense reduction in liver and spleen parasitic load by qPCR. The LAPSmP and LAPSmG vaccines showed exceptional results, indicating that they may be promising candidates as a VL vaccine.
format Artículo
id INIA2090
institution Institucional Nacional de Innovación Agraria
language Inglés
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher MDPI
publisherStr MDPI
record_format dspace
spelling INIA20902023-05-02T23:32:55Z Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster Maia Gonçalves, Ana Alice Ottino, Jennifer Costa Leite, Jaqueline Aparecida Resende, Lucilene Melo Júnior, Otoni Alves Silveira, Patrícia Santos Cardoso, Mariana Toshio Fujiwara, Ricardo Lacerda Bueno, Lilian Lima Santos, Renato Furtado de Carvalho, Tatiane Martins Garcia, Giani de Oliveira Paes, Paulo Ricardo Sobreira Galdino, Alexsandro Chávez Fumagalli, Miguel Angel Martins Melo, Marília Silveira Lemos, Denise Martins Filho, Olindo Assis Ornelas Dutra, Walderez Furtado Mosqueira, Vanessa Carla Cordeiro Giunchetti, Rodolfo Visceral leishmaniasis Nanotechnology Vaccine https://purl.org/pe-repo/ocde/ford#4.03.01 Leishmaniasis Nanotechnology Vaccines Leishmania Visceral leishmaniasis (VL) is a fatal disease caused by the protozoa Leishmania infantum for which dogs are the main reservoirs. A vaccine against canine visceral leishmaniasis (CVL) could be an important tool in the control of human and CVL by reducing the infection pressure of L. infantum. Despite the CVL vaccine available on the market, the Brazilian Ministry of Health did not implement the use of it in their control programs. In this sense, there is an urgent need to develop more efficient vaccines. In this study, the association between two polymeric nanoformulations, (poly (D, L-lactic) acid (PLA) polymer) loading Leishmania amazonensis antigens, was evaluated as a potential immunobiological agent against VL using golden hamsters as an experimental model. The results indicated that no significant adverse reactions were observed in animals vaccinated with LAPSmP. LAPSmP presented similar levels of total anti-Leishmania IgG as compared to LAPSmG. The LAPSmP and LAPSmG groups showed an intense reduction in liver and spleen parasitic load by qPCR. The LAPSmP and LAPSmG vaccines showed exceptional results, indicating that they may be promising candidates as a VL vaccine. 2023-02-23T15:26:20Z 2023-02-23T15:26:20Z 2023-01-02 info:eu-repo/semantics/article González, M.; Gonçalves, A.; Ottino, J.; Leite, J.; Resende, L.; Melo, O.; Silveira, P.; Cardoso, M.; Fujiwara, R.; Bueno, L.; Santos, R.; Carvalho, T.; Garcia, G.; Paes.; Galdino, A.; Chávez, M.; Melo, M.; Silveira, D.; Martins, O.; … Giunchetti, R. (2023). Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster. Vaccines, 11(1), 111. doi: 10.3390/vaccines11010111 2076-393X https://hdl.handle.net/20.500.12955/2090 https://doi.org/10.3390/vaccines11010111 eng urn:issn:2076-393X Vaccines info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf application/pdf MDPI CH Instituto Nacional de Innovación Agraria Repositorio Institucional - INIA
spellingShingle Visceral leishmaniasis
Nanotechnology
Vaccine
https://purl.org/pe-repo/ocde/ford#4.03.01
Leishmaniasis
Nanotechnology
Vaccines
Leishmania
Maia Gonçalves, Ana Alice
Ottino, Jennifer
Costa Leite, Jaqueline
Aparecida Resende, Lucilene
Melo Júnior, Otoni Alves
Silveira, Patrícia
Santos Cardoso, Mariana
Toshio Fujiwara, Ricardo
Lacerda Bueno, Lilian
Lima Santos, Renato
Furtado de Carvalho, Tatiane
Martins Garcia, Giani
de Oliveira Paes, Paulo Ricardo
Sobreira Galdino, Alexsandro
Chávez Fumagalli, Miguel Angel
Martins Melo, Marília
Silveira Lemos, Denise
Martins Filho, Olindo Assis
Ornelas Dutra, Walderez
Furtado Mosqueira, Vanessa Carla
Cordeiro Giunchetti, Rodolfo
Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster
title Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster
title_full Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster
title_fullStr Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster
title_full_unstemmed Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster
title_short Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster
title_sort vaccination with formulation of nanoparticles loaded with leishmania amazonensis antigens confers protection against experimental visceral leishmaniasis in hamster
topic Visceral leishmaniasis
Nanotechnology
Vaccine
https://purl.org/pe-repo/ocde/ford#4.03.01
Leishmaniasis
Nanotechnology
Vaccines
Leishmania
url https://hdl.handle.net/20.500.12955/2090
https://doi.org/10.3390/vaccines11010111
work_keys_str_mv AT maiagoncalvesanaalice vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT ottinojennifer vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT costaleitejaqueline vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT aparecidaresendelucilene vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT melojuniorotonialves vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT silveirapatricia vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT santoscardosomariana vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT toshiofujiwararicardo vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT lacerdabuenolilian vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT limasantosrenato vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT furtadodecarvalhotatiane vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT martinsgarciagiani vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT deoliveirapaespauloricardo vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT sobreiragaldinoalexsandro vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT chavezfumagallimiguelangel vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT martinsmelomarilia vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT silveiralemosdenise vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT martinsfilhoolindoassis vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT ornelasdutrawalderez vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT furtadomosqueiravanessacarla vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster
AT cordeirogiunchettirodolfo vaccinationwithformulationofnanoparticlesloadedwithleishmaniaamazonensisantigensconfersprotectionagainstexperimentalvisceralleishmaniasisinhamster